Kevin F. Fox
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kevin F. Fox has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Andrew J.S. Coats
Cardiac Medicine, Imperial College School of Medicine, National Heart and Lung Institute , Dovehouse Street, London, SW3 6LY
1 shared publicationDavid A. Wood
Cardiac Medicine, Imperial College School of Medicine, National Heart and Lung Institute , Dovehouse Street, London, SW3 6LY
1 shared publicationG. M. J. Watson
1 shared publicationGeorge C. Sutton
Cardiac Medicine, Imperial College School of Medicine, National Heart and Lung Institute , Dovehouse Street, London, SW3 6LY
1 shared publicationMartin R. Cowie
Department of Medicine and Therapeutics, Cardiology Research Group, University of Aberdeen , Polwarth Building, Foresterhill, Aberdeen, AB25 2ZD
1 shared publicationPhilip A. Poole-Wilson
Cardiac Medicine, Imperial College School of Medicine, National Heart and Lung Institute , Dovehouse Street, London, SW3 6LY
1 shared publication
Latest Publications
- Open Access
- 27 February 2010
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 11 (5) , 422-423
Are obesity and left ventricular dysfunction entwined?
This editorial refers to ‘Evaluation of left ventricular rotation in obese subjects by velocity vector imaging’ by Y. Deng et al., on page 424 in this issue.
- 27 February 2010
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 11 (5) , 422-423
Open AccessAre obesity and left ventricular dysfunction entwined?
This editorial refers to ‘Evaluation of left ventricular rotation in obese subjects by velocity vector imaging’ by Y. Deng et al., on page 424 in this issue.
- Open Access
- 1 December 2001
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
- Vol. 94 (12) , 717-718
Chest pain assessment services: the next steps
Improved care for patients presenting with chest pain remains high on the medical agenda. This is reflected not only in the National Service Framework (NSF),1 but also in the number and variety of publications in this area. The two articles in this issue illustrate that the questions are no longer about whether there should be specialized services for chest pain, but how best to organize such services, and the need to subject them to economic analysis. Just a year ago the question was posed: ‘Chest pain—please admit’: is there an alternative?2 The accepted answer now must be a conclusive ‘yes’. The challenge that remains is to refine the alternatives. This of itself represents a great (if as yet incomplete) victory for the protagonists of chest pain clinics and for the NSF.
- 1 December 2001
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
- Vol. 94 (12) , 717-718
Open AccessChest pain assessment services: the next steps
Improved care for patients presenting with chest pain remains high on the medical agenda. This is reflected not only in the National Service Framework (NSF),1 but also in the number and variety of publications in this area. The two articles in this issue illustrate that the questions are no longer about whether there should be specialized services for chest pain, but how best to organize such services, and the need to subject them to economic analysis. Just a year ago the question was posed: ‘Chest pain—please admit’: is there an alternative?2 The accepted answer now must be a conclusive ‘yes’. The challenge that remains is to refine the alternatives. This of itself represents a great (if as yet incomplete) victory for the protagonists of chest pain clinics and for the NSF.
- 1 December 2001
- Published by Informa Healthcare in Expert Opinion on Pharmacotherapy
- Vol. 2 (12) , 2079-2084
A critical evaluation of the NICE guidelines for post-myocardial infarction prophylaxis
The UK National Institute for Clinical Excellence (NICE) has recently published guidelines on prophylaxis for patients who have experienced a myocardial infarction (MI). Based on a previously commissioned extensive review of the literature, the recommendations are antiplatelet therapy, beta-blockers and angiotensin converting enzyme inhibitors (ACEIs) for all patients; statins for those with hypercholesterolaemia; spironolactone for those with moderate-to-severe heart failure (HF); and insulin for those with diabetes. While there may be concerns about some of the details (eg., the possible adverse interaction between aspirin and ACEIs), comments on the use of statins for those with HF, the lack of advice on the choice of lipid-lowering therapy for those intolerent of statins, the dangers of spironolactone therapy and the practicality of intensive insulin treatment, the guidelines are firmly based on sound evidence of efficacy and cost effectiveness. The NICE guidelines should therefore stimulate the provision of resources to address the gap between current practice and these recommendations.
- 1 December 2001
- Published by Informa Healthcare in Expert Opinion on Pharmacotherapy
- Vol. 2 (12) , 2079-2084
A critical evaluation of the NICE guidelines for post-myocardial infarction prophylaxis
The UK National Institute for Clinical Excellence (NICE) has recently published guidelines on prophylaxis for patients who have experienced a myocardial infarction (MI). Based on a previously commissioned extensive review of the literature, the recommendations are antiplatelet therapy, beta-blockers and angiotensin converting enzyme inhibitors (ACEIs) for all patients; statins for those with hypercholesterolaemia; spironolactone for those with moderate-to-severe heart failure (HF); and insulin for those with diabetes. While there may be concerns about some of the details (eg., the possible adverse interaction between aspirin and ACEIs), comments on the use of statins for those with HF, the lack of advice on the choice of lipid-lowering therapy for those intolerent of statins, the dangers of spironolactone therapy and the practicality of intensive insulin treatment, the guidelines are firmly based on sound evidence of efficacy and cost effectiveness. The NICE guidelines should therefore stimulate the provision of resources to address the gap between current practice and these recommendations.
- 1 December 2000
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 2 (4) , 423-429
A Rapid Access Heart Failure Clinic Provides a Prompt Diagnosis and Appropriate Management of New Heart Failure Presenting in the Community
Background and aims: The diagnosis of heart failure is an important clinical problem and yet reported diagnostic accuracy in primary care is less than 50%. We established a Rapid Access Heart Failure Clinic (RAHFC) in a district general hospital serving a population of 292000 in SE London, UK, to diagnose and manage new cases of heart failure presenting for the first time in the community. Methods: Patients with suspected new onset heart failure were referred by their Primary Care Physician without appointment for clinical assessment on the same or next working day. Assessment by a specialist registrar in cardiology included history, examination, chest X-ray, electrocardiogram (ECG) and echocardiogram. When a diagnosis of heart failure was made appropriate treatment, including angiotensin converting enzyme inhibitors (ACEI), was started. Results: Over 15 months 383 patients were seen (0.4 cases/100000 population/weekday) 178/383 (46%) were considered to have definite or possible heart failure at the initial assessment in the RAHFC. A normal ECG (negative predictive value 94%) and chest X-ray virtually excluded the diagnosis of heart failure. After subsequent specialist investigations and follow-up, including a trial of therapy where appropriate, 101/383 (26%) were finally diagnosed as clinical heart failure. ACEI therapy was commenced in 56/57 (98%) of patients in whom it was considered appropriate. Conclusion: The RAHFC provided rapid assessment, prompt diagnosis and early introduction of life prolonging therapy for patients presenting with suspected heart failure in the community.
- 1 December 2000
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 2 (4) , 423-429
A Rapid Access Heart Failure Clinic Provides a Prompt Diagnosis and Appropriate Management of New Heart Failure Presenting in the Community
Background and aims: The diagnosis of heart failure is an important clinical problem and yet reported diagnostic accuracy in primary care is less than 50%. We established a Rapid Access Heart Failure Clinic (RAHFC) in a district general hospital serving a population of 292000 in SE London, UK, to diagnose and manage new cases of heart failure presenting for the first time in the community. Methods: Patients with suspected new onset heart failure were referred by their Primary Care Physician without appointment for clinical assessment on the same or next working day. Assessment by a specialist registrar in cardiology included history, examination, chest X-ray, electrocardiogram (ECG) and echocardiogram. When a diagnosis of heart failure was made appropriate treatment, including angiotensin converting enzyme inhibitors (ACEI), was started. Results: Over 15 months 383 patients were seen (0.4 cases/100000 population/weekday) 178/383 (46%) were considered to have definite or possible heart failure at the initial assessment in the RAHFC. A normal ECG (negative predictive value 94%) and chest X-ray virtually excluded the diagnosis of heart failure. After subsequent specialist investigations and follow-up, including a trial of therapy where appropriate, 101/383 (26%) were finally diagnosed as clinical heart failure. ACEI therapy was commenced in 56/57 (98%) of patients in whom it was considered appropriate. Conclusion: The RAHFC provided rapid assessment, prompt diagnosis and early introduction of life prolonging therapy for patients presenting with suspected heart failure in the community.
- 12 June 2000
- Published by Elsevier in International Journal of Cardiology
- Vol. 74 (1) , 75-76
Discovering the aetiology of heart failure, one link in the chain to improved survival
- 12 June 2000
- Published by Elsevier in International Journal of Cardiology
- Vol. 74 (1) , 75-76
Discovering the aetiology of heart failure, one link in the chain to improved survival